Skip to main content
editorial
. 2021 Oct 19;3(4):606–610. doi: 10.1016/j.jaccao.2021.06.001

Figure 1.

Figure 1

Imaging, Biomarkers, and Survival in Amyloid Cardiomyopathy

(A) Imaging and biomarker parameters by amyloidosis subtypes. (B) Overall survival in AL (light chain) and ATTR (transthyretin amyloid) cardiomyopathy.